3-Jan-2025
No headlines found.
BeautyHealth Appoints Stephen J. Fanning to Board of Directors
Business Wire (Tue, 17-Dec 4:30 PM ET)
BeautyHealth Releases 2024 Skintuition Report
Business Wire (Wed, 11-Dec 8:00 AM ET)
Business Wire (Fri, 6-Dec 9:30 AM ET)
BeautyHealth Reports Third Quarter 2024 Financial Results
Business Wire (Tue, 12-Nov 4:05 PM ET)
BeautyHealth to Report Third Quarter 2024 Financial Results on November 12, 2024
Business Wire (Fri, 8-Nov 8:00 AM ET)
Business Wire (Thu, 17-Oct 3:28 PM ET)
Business Wire (Tue, 15-Oct 4:10 PM ET)
Hydrafacial Announces Glow Getter Scholarship Program in Support of Estheticians
Business Wire (Tue, 15-Oct 10:51 AM ET)
The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets, and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products.
Beauty Health Company - Class A trades on the NASDAQ stock market under the symbol SKIN.
As of January 3, 2025, SKIN stock price climbed to $1.65 with 294,513 million shares trading.
SKIN has a beta of 2.75, meaning it tends to be more sensitive to market movements. SKIN has a correlation of 0.17 to the broad based SPY ETF.
SKIN has a market cap of $204.63 million. This is considered a Small Cap stock.
Last quarter Beauty Health Company - Class A reported $79 million in Revenue and -$.15 earnings per share. This beat revenue expectation by $5 million and missed earnings estimates by -$.03.
In the last 3 years, SKIN traded as high as $24.10 and as low as $.91.
The top ETF exchange traded funds that SKIN belongs to (by Net Assets): VTI, IWM, VXF, VDC, IWO.
SKIN has underperformed the market in the last year with a return of -44.3%, while SPY returned +27.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in SKIN shares. However, SKIN has outperformed the market in the last 3 month and 2 week periods, returning +13.0% and +13.0%, while SPY returned +4.6% and +0.1%, respectively. This indicates SKIN has been having a stronger performance recently.
SKIN support price is $1.53 and resistance is $1.69 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SKIN shares will trade within this expected range on the day.